(Q38045914)

27 August 2017

title

Issues and controversies surrounding the diagnosis and treatment of social anxiety disorder (English)

1 reference

27 August 2017

Kristy L Dalrymple

1

1 reference

27 August 2017

language of work or name

1 reference

1 August 2012

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

27 August 2017

published in

1 reference

27 August 2017

volume

12

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

993-1008; quiz 1009

1 reference

Social phobia: overview of community surveys.

27 August 2017

cites work

1 reference

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

Screening for social fears and social anxiety disorder in psychiatric outpatients

21 January 2018

1 reference

Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life

21 January 2018

1 reference

Recovery from social phobia in the community and its predictors: data from a longitudinal epidemiological study

21 January 2018

1 reference

Social phobia and number of social fears, and their association with comorbidity, health-related quality of life and help seeking: a population-based study.

21 January 2018

1 reference

Impact of generalized social anxiety disorder in managed care

21 January 2018

1 reference

Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study.

21 January 2018

1 reference

Disability and quality of life in social phobia: epidemiologic findings

21 January 2018

1 reference

Economic costs of social phobia: a population-based study.

21 January 2018

1 reference

Social anxiety disorder: trends and translational research.

21 January 2018

1 reference

What is a mental/psychiatric disorder? From DSM-IV to DSM-V

21 January 2018

1 reference

fMRI reveals amygdala activation to human faces in social phobics

21 January 2018

1 reference

Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia

21 January 2018

1 reference

Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study

21 January 2018

1 reference

Neuroimaging in social anxiety disorder: a systematic review of the literature

21 January 2018

1 reference

A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder

21 January 2018

1 reference

A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety.

21 January 2018

1 reference

Striatal function in generalized social phobia: a functional magnetic resonance imaging study.

21 January 2018

1 reference

Response to emotional expressions in generalized social phobia and generalized anxiety disorder: evidence for separate disorders

21 January 2018

1 reference

HPA axis response to a psychological stressor in generalised social phobia

21 January 2018

1 reference

Stress-induced changes in human salivary alpha-amylase activity -- associations with adrenergic activity

21 January 2018

1 reference

Salivary cortisol levels in socially phobic adolescent girls

21 January 2018

1 reference

Embarrassment and social phobia: the role of parasympathetic activation.

21 January 2018

1 reference

Low dopamine D(2) receptor binding potential in social phobia

21 January 2018

1 reference

A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder.

21 January 2018

1 reference

Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia

21 January 2018

1 reference

Genetic linkage to the serotonin transporter protein and 5HT2A receptor genes excluded in generalized social phobia

21 January 2018

1 reference

The role of parental psychopathology and family environment for social phobia in the first three decades of life

21 January 2018

1 reference

The genetic epidemiology of irrational fears and phobias in men.

21 January 2018

1 reference

Heritability of self-reported phobic fear

21 January 2018

1 reference

Vulnerability factors among children at risk for anxiety disorders

21 January 2018

1 reference

The origins of social phobia

21 January 2018

1 reference

Social phobia. Review of a neglected anxiety disorder

21 January 2018

1 reference

Trends in the prevalence of social phobia in the United States: a synthetic cohort analysis of changes over four decades

21 January 2018

1 reference

Are we overpathologizing the socially anxious? Social phobia from a harmful dysfunction perspective.

21 January 2018

1 reference

The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics

21 January 2018

1 reference

Social phobia in the general population: prevalence and sociodemographic profile

21 January 2018

1 reference

Justifying the diagnostic status of social phobia: a reply to Wakefield, Horwitz, and Schmitz

21 January 2018

1 reference

Clinician recognition of anxiety disorders in depressed outpatients.

21 January 2018

1 reference

Social phobia in general health care: an unrecognised undertreated disabling disorder

21 January 2018

1 reference

Public-speaking fears in a community sample. Prevalence, impact on functioning, and diagnostic classification

21 January 2018

1 reference

Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey

21 January 2018

1 reference

Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates

21 January 2018

1 reference

Shyness: relationship to social phobia and other psychiatric disorders

21 January 2018

1 reference

Social anxiety disorder: what are we losing with the current diagnostic criteria?

21 January 2018

1 reference

A taxometric investigation of the latent structure of social anxiety disorder in outpatients with anxiety and mood disorders.

21 January 2018

1 reference

The latent structure of social anxiety disorder: consequences of shifting to a dimensional diagnosis

21 January 2018

1 reference

Social anxiety disorder: questions and answers for the DSM-V.

21 January 2018

1 reference

Generalized social phobia and avoidant personality disorder: meaningful distinction or useless duplication?

21 January 2018

1 reference

Social phobia and avoidant personality disorder as related to parental history of social anxiety: a general population study

21 January 2018

1 reference

The relationship between avoidant personality disorder and social phobia.

21 January 2018

1 reference

Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study

21 January 2018

1 reference

Treatment-seeking for social anxiety disorder in a general outpatient psychiatry setting

21 January 2018

1 reference

Differences in clinical presentation between depressed outpatients wanting versus not wanting treatment for comorbid social anxiety disorder

21 January 2018

1 reference

Barriers to treatment seeking for anxiety disorders: initial data on the role of mental health literacy.

21 January 2018

1 reference

Social phobia. Comorbidity and morbidity in an epidemiologic sample

21 January 2018

1 reference

Psychiatrists' ascertained treatment needs for mental disorders in a population-based sample

21 January 2018

1 reference

Does comorbid Social Anxiety Disorder impact the clinical presentation of principal Major Depressive Disorder?

21 January 2018

1 reference

Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults

21 January 2018

1 reference

Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms

21 January 2018

1 reference

Long-term depression versus episodic major depression: results from the prospective Zurich study of a community sample

21 January 2018

1 reference

Change in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: a prospective cohort study.

21 January 2018

1 reference

The treatment of social anxiety disorder

21 January 2018

1 reference

Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial

21 January 2018

1 reference

Using the Internet to provide cognitive behaviour therapy

21 January 2018

1 reference

Pharmacological treatment of social anxiety disorder: a meta-analysis

21 January 2018

1 reference

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

21 January 2018

1 reference

Psychological and pharmacological treatments of social phobia: a meta-analysis

21 January 2018

1 reference

Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia

21 January 2018

1 reference

Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study

21 January 2018

1 reference

Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.

21 January 2018

1 reference

Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment

21 January 2018

1 reference

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia

21 January 2018

1 reference

A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder

21 January 2018

1 reference

Exposure therapy and sertraline in social phobia: I-year follow-up of a randomised controlled trial

21 January 2018

1 reference

Optimizing inhibitory learning during exposure therapy

21 January 2018

1 reference

Treatment of social phobia with clonazepam and placebo.

21 January 2018

1 reference

Discontinuation of clonazepam in the treatment of social phobia.

21 January 2018

1 reference

Benzodiazepine tapering: a prospective study

21 January 2018

1 reference

Benzodiazepines revisited--will we ever learn?

21 January 2018

1 reference

Withdrawing Benzodiazepines in Primary Care

21 January 2018

1 reference

Suicidality, depression, and mental health service use in Canada.

21 January 2018

1 reference

National trends in psychotropic medication polypharmacy in office-based psychiatry

21 January 2018

1 reference

Patterns and correlates of benzodiazepine use in the French general population

21 January 2018

1 reference

Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia

21 January 2018

1 reference

Social phobia: long-term treatment outcome and prediction of response--a moclobemide study

21 January 2018

1 reference

Pre-existing antidepressants and the outcome of group cognitive behaviour therapy for social phobia

21 January 2018

1 reference

Behavioral and neural analysis of extinction

21 January 2018

1 reference

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

21 January 2018

1 reference

A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder

21 January 2018

1 reference

Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

D-cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial.

21 January 2018

1 reference

Fear erasure in mice requires synergy between antidepressant drugs and extinction training.

21 January 2018

1 reference

Social anxiety and marijuana-related problems: the role of social avoidance

21 January 2018

1 reference

Self-help cognitive-behavioral therapy with minimal therapist contact for social phobia: a controlled trial

21 January 2018

1 reference

Treating university students with social phobia and public speaking fears: Internet delivered self-help with or without live group exposure sessions.

21 January 2018

1 reference

Computer-aided self-exposure therapy for phobia/panic disorder: a pilot economic evaluation.

21 January 2018

1 reference

Impact of depressive symptoms on the treatment of generalized social anxiety disorder

21 January 2018

1 reference

Impact of depression on treatment effectiveness and gains maintenance in social phobia: a naturalistic study of cognitive behavior group therapy.

21 January 2018

1 reference

Citalopram treatment of social anxiety disorder with comorbid major depression

21 January 2018

1 reference

Comorbid generalized anxiety disorder in primary social phobia: symptom severity, functional impairment, and treatment response.

21 January 2018

1 reference

Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial.

21 January 2018

1 reference

A study of the discriminative validity of a screening tool (MINI-SPIN) for social anxiety disorder applied to Brazilian university students

21 January 2018

1 reference

Conceptual background, development, and preliminary data from the unified protocol for transdiagnostic treatment of emotional disorders

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.12.81

1 reference

27 August 2017

1 reference